Gujarat Themis Biosyn Limited (GUJTHEM.BO)
INR 277.35
(5.16%)
INR 277.35
(5.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 156.84 Million INR | -72.64% |
| 2022 | 465.5 Million INR | 26.75% |
| 2021 | 367.25 Million INR | 23.37% |
| 2020 | 297.68 Million INR | -23.63% |
| 2019 | 389.78 Million INR | 1226.83% |
| 2018 | 29.37 Million INR | 60.46% |
| 2017 | 18.3 Million INR | 15.97% |
| 2016 | 15.78 Million INR | 17.38% |
| 2015 | 13.44 Million INR | -94.78% |
| 2014 | 257.56 Million INR | 230.49% |
| 2013 | 77.93 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 29.46 Million INR | 75.15% |
| 2024 Q2 | 24.23 Million INR | -17.76% |
| 2023 Q3 | 38.33 Million INR | -73.82% |
| 2023 Q4 | 16.82 Million INR | -56.12% |
| 2023 FY | 127.36 Million INR | -72.64% |
| 2023 Q1 | 123.98 Million INR | 9.89% |
| 2023 Q2 | 146.41 Million INR | 18.1% |
| 2022 Q3 | 133.81 Million INR | 20.07% |
| 2022 Q2 | 111.44 Million INR | 3.75% |
| 2022 Q1 | 107.41 Million INR | 47.98% |
| 2022 FY | 465.5 Million INR | 26.75% |
| 2022 Q4 | 112.82 Million INR | -15.69% |
| 2021 Q2 | 15.17 Million INR | 14.5% |
| 2021 Q4 | 72.58 Million INR | 318.59% |
| 2021 Q1 | 13.25 Million INR | 54.69% |
| 2021 FY | 367.25 Million INR | 23.37% |
| 2021 Q3 | 17.34 Million INR | 14.28% |
| 2020 Q2 | 97.62 Million INR | 17.88% |
| 2020 Q1 | 82.81 Million INR | -4.99% |
| 2020 FY | 297.68 Million INR | -23.63% |
| 2020 Q4 | 8.56 Million INR | -51.02% |
| 2020 Q3 | 17.49 Million INR | -82.08% |
| 2019 Q2 | 111.97 Million INR | 18.2% |
| 2019 FY | 389.78 Million INR | 1226.83% |
| 2019 Q4 | 87.16 Million INR | -9.12% |
| 2019 Q3 | 95.91 Million INR | -14.34% |
| 2019 Q1 | 94.73 Million INR | 56.04% |
| 2018 Q2 | 76.84 Million INR | 4.5% |
| 2018 Q1 | 73.53 Million INR | -12.35% |
| 2018 Q4 | 60.71 Million INR | -17.4% |
| 2018 FY | 29.37 Million INR | 60.46% |
| 2018 Q3 | 73.5 Million INR | -4.35% |
| 2017 FY | 18.3 Million INR | 15.97% |
| 2017 Q4 | 83.9 Million INR | 17.53% |
| 2017 Q1 | 70.57 Million INR | -8.76% |
| 2017 Q2 | 77.16 Million INR | 9.34% |
| 2017 Q3 | 71.38 Million INR | -7.49% |
| 2016 Q3 | 71.21 Million INR | -3.08% |
| 2016 Q4 | 77.35 Million INR | 8.61% |
| 2016 Q2 | 73.48 Million INR | 22.05% |
| 2016 Q1 | 60.2 Million INR | -1.17% |
| 2016 FY | 15.78 Million INR | 17.38% |
| 2015 Q1 | 68.84 Million INR | -2.43% |
| 2015 Q4 | 60.92 Million INR | -9.64% |
| 2015 Q3 | 67.42 Million INR | -3.62% |
| 2015 Q2 | 69.95 Million INR | 1.61% |
| 2015 FY | 13.44 Million INR | -94.78% |
| 2014 Q2 | 65.08 Million INR | 4.28% |
| 2014 Q1 | 62.41 Million INR | 10.49% |
| 2014 FY | 257.56 Million INR | 230.49% |
| 2014 Q4 | 70.56 Million INR | 10.88% |
| 2014 Q3 | 63.63 Million INR | -2.22% |
| 2013 Q1 | 66.03 Million INR | -0.99% |
| 2013 Q2 | 65 Million INR | -1.56% |
| 2013 FY | 77.93 Million INR | 0.0% |
| 2013 Q3 | 59.56 Million INR | -8.37% |
| 2013 Q4 | 56.48 Million INR | -5.16% |
| 2012 Q4 | 66.69 Million INR | 17.0% |
| 2012 Q1 | 51.31 Million INR | 31.5% |
| 2012 Q3 | 57 Million INR | -20.15% |
| 2012 Q2 | 71.38 Million INR | 39.1% |
| 2011 Q3 | 15.75 Million INR | 0.0% |
| 2011 Q4 | 39.02 Million INR | 147.66% |
| 2008 Q4 | 36.42 Million INR | 0.0% |
| 2007 Q4 | 38.74 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 277.6 Million INR | 43.499% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -852.493% |
| MedPlus Health Services Limited | 2.42 Billion INR | 93.53% |
| ANG Lifesciences India Limited | 219.92 Million INR | 28.683% |
| Add-Shop E-Retail Limited | 146.52 Million INR | -7.044% |
| Bacil Pharma Limited | 1.87 Million INR | -8267.896% |
| BDH Industries Limited | 57.03 Million INR | -175.016% |
| Beryl Drugs Limited | 93.77 Million INR | -67.266% |
| Cian Healthcare Limited | 59.19 Million INR | -164.949% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -7955.829% |
| Concord Drugs Limited | 91.83 Million INR | -70.798% |
| Deccan Health Care Limited | 36.24 Million INR | -332.777% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | -18.448% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -5913.053% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 64.125% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | -4.9% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 36.992% |
| Makers Laboratories Limited | 83.1 Million INR | -88.736% |
| Medi-Caps Limited | 93.11 Million INR | -68.439% |
| Panchsheel Organics Limited | 68.15 Million INR | -130.119% |
| Parmax Pharma Limited | 99.31 Million INR | -57.925% |
| Parnax Lab Limited | 80.59 Million INR | -94.619% |
| Patidar Buildcon Limited | 1.81 Million INR | -8560.795% |
| Phaarmasia Limited | 50.52 Million INR | -210.428% |
| Vikram Thermo (India) Limited | 104.27 Million INR | -50.415% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 24.91% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -10191.798% |
| Smruthi Organics Limited | 261.73 Million INR | 40.074% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -392.347% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | -7.363% |
| Trident Lifeline Limited | 46.87 Million INR | -234.635% |
| Transchem Limited | 8.47 Million INR | -1751.139% |
| Trinity League India Limited | -1.08 Million INR | 14542.634% |
| Tyche Industries Limited | 182.04 Million INR | 13.84% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -677.779% |
| Vivanza Biosciences Limited | 4.55 Million INR | -3343.403% |
| PRAVEG LIMITED | 77.18 Million INR | -103.217% |
| Sastasundar Ventures Limited | 846.78 Million INR | 81.477% |
| Sunil Healthcare Limited | 438.1 Million INR | 64.199% |
| Syschem (India) Limited | 64.13 Million INR | -144.569% |
| Zenith Healthcare Limited | 45.97 Million INR | -241.135% |
| Zenlabs Ethica Limited | 57.89 Million INR | -170.916% |
| Mercury Laboratories Limited | 217.24 Million INR | 27.801% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -1175.127% |
| Vasundhara Rasayans Limited | 145.5 Million INR | -7.793% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 14.795% |
| Roopa Industries Limited | 24.63 Million INR | -536.684% |
| PANJON LTD. | 33.77 Million INR | -364.333% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -105.045% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -146485.981% |
| Anuh Pharma Limited | 263.04 Million INR | 40.373% |
| Crestchem Limited | 50.8 Million INR | -208.738% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -3529.037% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 26.329% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 56.487% |
| Trimurthi Limited | 4.81 Million INR | -3160.175% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -88.852% |
| Norris Medicines Limited | 18.2 Million INR | -761.553% |
| Veerhealth Care Limited | 15.38 Million INR | -919.679% |
| Lactose (India) Limited | 111.66 Million INR | -40.466% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -559.575% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 44.149% |
| Gennex Laboratories Limited | 130.37 Million INR | -20.303% |
| Denis Chem Lab Limited | 453.36 Million INR | 65.404% |
| Colinz Laboratories Limited | 31.19 Million INR | -402.747% |
| Godavari Drugs Limited | 359.01 Million INR | 56.311% |
| Zenotech Laboratories Limited | 94.82 Million INR | -65.412% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | -50.619% |
| Bharat Parenterals Limited | 255.97 Million INR | 38.726% |
| Coral Laboratories Limited | 189.75 Million INR | 17.344% |
| Evoq Remedies Limited | 4.51 Million INR | -3372.371% |
| Kerala Ayurveda Limited | 399.64 Million INR | 60.753% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -6224.476% |
| Natural Capsules Limited | 444.7 Million INR | 64.73% |
| Auro Laboratories Limited | 157.37 Million INR | 0.336% |